Stroke Prevention in Atrial Fibrillation: Supporting Effective DOAC Therapy – Canadian Council On Continuing Education In Pharmacy (CCCEP)

After successful completion of the program, the participant will be able to:

• Make recommendations that support the safe, effective, and appropriate use of DOAC therapy in patients with NVAF based on patient characteristics.
• Describe the role of the pharmacist in stroke prevention for patients who have NVAF and are receiving DOAC therapy.
• Counsel patients on the safe and appropriate use of DOAC medications to support best outcomes including adherence.

DOAC = direct oral anticoagulant

NVAF = non-valvular atrial fibrillation